Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Newlight Partners is an independent private equity investment firm focused on building businesses in partnership with management teams. It invests thematically across several sectors, including healthcare, decarbonization, digital transformation, and financial services. The team spun out from Soros Fund Management’s Strategic Investments Group in 2018 and has since managed over $3.5–$4 billion in assets under management[1][5][7]. In healthcare, its investments include Oak Street Health (primary care for Medicare patients) and Zing Health (Medicare Advantage plans), both of which focus on value-based care models[4][7].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Newlight Partners.